Saad Alhumaid, Woldesellassie M Bezabhe, Mackenzie Williams, Gregory M Peterson
{"title":"Trends in renal function testing in patients with dementia: a repeated cross-sectional analysis in Australian general practice.","authors":"Saad Alhumaid, Woldesellassie M Bezabhe, Mackenzie Williams, Gregory M Peterson","doi":"10.1007/s40620-025-02256-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is little published evidence regarding the extent to which renal function testing is performed in older Australians, particularly those with dementia.</p><p><strong>Objectives: </strong>To examine the prevalence and temporal trends in renal function testing and the factors associated with renal function testing in patients with dementia using Australian general practice data.</p><p><strong>Methods: </strong>Ten consecutive cross-sectional analyses were performed to evaluate the proportion of patients aged ≥ 65 years with a recorded diagnosis of dementia, along with matched controls, who had renal function tests using estimated glomerular filtration rate (eGFR) within the twelve months of each year from 2011 to 2020.</p><p><strong>Results: </strong>Before matching, 24,701 patients (59.2% females) with, and 72,105 patients (59.2% females) without, a recorded diagnosis of dementia were included. Over the study period, renal function testing increased in both groups, although less for the patients with dementia; from 38.6% (95% CI 37.1-40.0%) in 2011 to 41.9% (95% CI 41-42.9%; p for trend < 0.001) in 2020 in the dementia group, and 49% (95% CI 47.6-50.5%) to 60.4% (95% CI 59.5-61.4%; p for trend < 0.001) in the matched controls. Younger patients with dementia (< 85 years of age), males, and those with more general practitioner visits in the preceding 12 months, hypertension, diabetes, chronic kidney disease, osteoporosis, or pain were most likely to have renal function testing.</p><p><strong>Conclusion: </strong>Rates of renal function testing in primary care patients with dementia in Australia were significantly lower than for matched controls, and improved only marginally between 2011 and 2020.</p>","PeriodicalId":16542,"journal":{"name":"Journal of Nephrology","volume":" ","pages":"1855-1863"},"PeriodicalIF":2.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40620-025-02256-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There is little published evidence regarding the extent to which renal function testing is performed in older Australians, particularly those with dementia.
Objectives: To examine the prevalence and temporal trends in renal function testing and the factors associated with renal function testing in patients with dementia using Australian general practice data.
Methods: Ten consecutive cross-sectional analyses were performed to evaluate the proportion of patients aged ≥ 65 years with a recorded diagnosis of dementia, along with matched controls, who had renal function tests using estimated glomerular filtration rate (eGFR) within the twelve months of each year from 2011 to 2020.
Results: Before matching, 24,701 patients (59.2% females) with, and 72,105 patients (59.2% females) without, a recorded diagnosis of dementia were included. Over the study period, renal function testing increased in both groups, although less for the patients with dementia; from 38.6% (95% CI 37.1-40.0%) in 2011 to 41.9% (95% CI 41-42.9%; p for trend < 0.001) in 2020 in the dementia group, and 49% (95% CI 47.6-50.5%) to 60.4% (95% CI 59.5-61.4%; p for trend < 0.001) in the matched controls. Younger patients with dementia (< 85 years of age), males, and those with more general practitioner visits in the preceding 12 months, hypertension, diabetes, chronic kidney disease, osteoporosis, or pain were most likely to have renal function testing.
Conclusion: Rates of renal function testing in primary care patients with dementia in Australia were significantly lower than for matched controls, and improved only marginally between 2011 and 2020.
背景:关于澳大利亚老年人,特别是痴呆症患者进行肾功能检查的程度,几乎没有发表的证据。目的:利用澳大利亚全科医生的数据,研究痴呆患者肾功能检测的流行率和时间趋势,以及与肾功能检测相关的因素。方法:进行了10个连续的横断面分析,以评估2011年至2020年每年12个月内使用估计的肾小球滤过率(eGFR)进行肾功能检查的65岁以上有痴呆记录的患者的比例,以及匹配的对照组。结果:在配对前,有24,701名患者(59.2%的女性)和72,105名患者(59.2%的女性)未被诊断为痴呆。在研究期间,两组患者的肾功能测试都有所增加,但痴呆患者的肾功能测试有所减少;从2011年的38.6% (95% CI 37.1-40.0%)到41.9% (95% CI 41-42.9%);结论:澳大利亚初级保健痴呆患者的肾功能检测率显著低于匹配对照组,2011年至2020年间仅略有改善。
期刊介绍:
Journal of Nephrology is a bimonthly journal that considers publication of peer reviewed original manuscripts dealing with both clinical and laboratory investigations of relevance to the broad fields of Nephrology, Dialysis and Transplantation. It is the Official Journal of the Italian Society of Nephrology (SIN).